FASLG and autoimmune polyendocrinopathy: Of note, all included patients received the background therapy with hydroxychloroquine, which has been verified to have a multifaceted effect in primary APS, including the thromboprotective role as well as the potential to lowering aPL levels and increasing platelet count (25–27).